Free Trial

Alzamend Neuro (ALZN) Institutional Ownership

Alzamend Neuro logo
$1.03 -0.01 (-0.96%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$1.03 0.00 (0.00%)
As of 08:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Alzamend Neuro (NASDAQ:ALZN)

Current
Institutional Ownership
Percentage
49.61%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$58.24K
Number of
Institutional Sellers
(last 12 months)
0
Get ALZN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Alzamend Neuro stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ALZN Institutional Buying and Selling by Quarter

Alzamend Neuro Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/12/2026 DRW Securities LLC116,319$212K0.0%+27.5%3.059%
2/9/2026Geode Capital Management LLC27,506$50K0.0%+33.7%0.723%
2/17/2025Citadel Advisors LLC30,638$36K0.0%N/A0.564%
2/12/2025Geode Capital Management LLC33,540$39K0.0%N/A0.618%
5/20/2024Virtu Financial LLC26,482$26K0.0%N/A0.385%
2/2/2024Truist Financial Corp154,327$137K0.0%-93.3%2.168%
5/11/2022RFG Advisory LLC250,000$308K0.0%N/A0.277%
5/9/2022Qube Research & Technologies Ltd78,465$97K0.0%N/A0.087%
4/22/2022Truist Financial Corp2,314,907$2.85M0.0%N/A2.569%


ALZN Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Alzamend Neuro shares: DRW Securities LLC ($212K), Geode Capital Management LLC ($50K), and Citadel Advisors LLC ($36K), Virtu Financial LLC ($26K).Learn more on Alzamend Neuro's institutional investors.

49.61% of Alzamend Neuro's stock is owned by institutional investors. Learn more on ALZN's institutional investor holdings.

The following institutional investors have purchased Alzamend Neuro's stock in the last 24 months: Geode Capital Management LLC ($40.47K), Citadel Advisors LLC ($30.64K), Virtu Financial LLC ($26.48K), and DRW Securities LLC ($25.07K).

Institutional investors have bought a total of 32,002 shares in the last 24 months. This purchase volume represents approximately $58.24K in transactions.



This page (NASDAQ:ALZN) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners